🇺🇸 FDA
Pipeline program

Liquid Biopsy (SPOT-MAS Assay)

2024-3143

Unknown other active

Quick answer

Liquid Biopsy (SPOT-MAS Assay) for Lung Cancer is a Unknown program (other) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Lung Cancer
Phase
Unknown
Modality
other
Status
active

Clinical trials